Participation of nitric oxide synthase and cyclooxygenase-2 in the salivary secretion of hypothyroid endotoxemic rats

Purpose: In the present study the participation of nitric oxide synthase (NOS) and cyclooxygenase-2 (COX-2) on salivary secretion in endotoxemic hypothyroid rats was investigated. Methods: Male Wistar rats with an initial weight of 180 g were distributed into two groups, normal (N) or treated with p...

ver descrição completa

Detalhes bibliográficos
Autores: Rodriguez, Tania Tavares, Dantas, Victor Trocoli Abdon, Ramalho, Maria José Pedreira
Formato: artículo
Estado:Versión publicada
Fecha de publicación:2009
País:Brasil
Recursos:Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS)
Repositorio:Revista odonto ciência (Online)
Idioma:inglés
OAI Identifier:oai:ojs.revistaseletronicas.pucrs.br:article/4654
Acesso em linha:https://revistaseletronicas.pucrs.br/fo/article/view/4654
Access Level:acceso abierto
Palavra-chave:Hypothyroidism
nitric oxide synthase
cyclooxygenase-2
saliva
endotoxemia
Salivary function
Descrição
Resumo:Purpose: In the present study the participation of nitric oxide synthase (NOS) and cyclooxygenase-2 (COX-2) on salivary secretion in endotoxemic hypothyroid rats was investigated. Methods: Male Wistar rats with an initial weight of 180 g were distributed into two groups, normal (N) or treated with propylthiouracil, 0.05 g/100 mL, administered orally for 5 weeks to induce hypothyroidism. Both groups were treated with lypopolysaccharide (LPS) (2.5 mg/kg; i.p.) to induce endotoxemia, or saline solution (SL), 90 min before salivary stimulation with pilocarpine (5 mg/kg; i.p.). Normal and PTU rats were divided into two groups each (n=07/09), receiving either L-NAME (10 mg/kg; i.p.), NOS inhibitor, or meloxicam (MLX) (0.5 mg/kg; i.p.), preferential COX-2 inhibitor, 30 min before endotoxemia challenge. Saliva was collected over a 15 min period (μL/min/100 g body wt.) from the time of the first drop of saliva. Results: Hypothyroidism decreased salivary flow rate in both groups of rats (LPS and SL). Endotoxemia and NOS inhibition by L-NAME reduced salivary flow in N rats. Meloxicam stimulated salivary secretion in the physiological state and systemic inflammation, induced by LPS, in N and PTU rats (Mann-Whitney Test; P < 0.05). Conclusion: In hypothyroid endotoxemic rats, it is COX-2 that modulates salivary secretion, not NOS.